page 4580Case 06: Esophageal Cancer to Metastasis to the Intra-abdominal Lymph Nodes

Case 06: Esophageal Cancer to Metastasis to the Intra-abdominal Lymph Nodes

Case 06: Esophageal Cancer to Metastasis to the Intra-abdominal Lymph Nodes

Treatment Performed

“Combined immunotherapy for cancer” was performed for an esophageal cancer with metastasis to the intra-abdominal lymph nodes, by combining the cancer peptide vaccine therapy and a drug to inhibit immunosuppression.

Treatment Outcome

Permanent cure with tumor disappearance

Before treatment
After treatment
Before treatment
2 months after treatment initiation
8 months after treatment initiation
11 months after treatment initiation
50 months after treatment initiation

The level of killer T cells prominently increased, and the lymphocytes in the blood showed a strong immune response to cancer antigens.